Introduction
============

Natural products are considered as specialized metabolites that often appear to play no part in the primary metabolism of the producing organism but instead are thought to confer an evolutionary advantage under specific environmental conditions ([@B8]). They occupy a diverse chemical structural space that is unmatched by synthetic compounds and remain an eminent source for new drug leads. Of the 1562 new chemical entities (NCEs) which were approved by the FDA covering all diseases/sources in the time frame spanning January 1981 until December 2014, about 60% are natural products, their analogs, or mimics ([@B21]). Additionally, there is a significant number of natural product or natural product-derived drugs currently in development pipeline. For example, between 2008 and 2013, approximately 100 drug candidates based on natural products were in various phases of clinical trials, or in the final stage of registration ([@B7]).

Microorganisms of both terrestrial and marine origin have a long track record as important sources of novel bioactive natural products. However, the frequent re-isolation of known compounds is one of the major challenges in the process of the discovery of new natural products. Recent advances in microbial genomics have unequivocally demonstrated that the biosynthetic potential of microbes for producing natural products is much higher than currently appreciated ([@B14]), but it is commonly believed that a significant number of microbial gene clusters may be silent under standard laboratory fermentation conditions.

In the last decade, several methods have been developed to eventually activate these cryptic biosynthetic pathways and hence, to elicit the production of hitherto unexpressed chemical diversity. Genetic engineering ([@B4]), epigenetic modifiers ([@B22]), and the OSMAC approach ([@B6]) are currently the most commonly applied strategies to increase chemical diversity in microorganisms through manipulation or activation of biosynthetic genes ([@B16]; [@B19]; [@B5]). In addition to this, microbial co-cultivation (also called mixed fermentation), involving the cultivation of two or more microorganisms in the same confined environment, has also successfully been used for the induction of the expression of otherwise cryptic pathways, leading to the production of new microbial natural products. Co-cultivation can be considered an experimental imitation of the competition within natural microbe communities at a laboratory scale which could encourage the production of secondary metabolites, for example *via* signaling molecules (auto-regulator/quorum sensing molecules, siderophores, etc.) in their environment ([@B5]; [@B20]). Alternative interpretations suggest that this effect could be related to the production of enzymes that activate the metabolite precursor produced by the producer strain, yielding the active metabolite, or that the inducer strain may induce epigenetic modifications in the producer strain ([@B1]). Even though the precise mechanism behind these microbial interactions may thus not be clear, the advantage of the co-cultivation methodology is that prior knowledge of the signaling mechanism is not required. However, it is worth noting that in many cases, direct contact was necessary between bacteria/fungi to observe such effects ([@B30]).

There are a number of recent studies which have demonstrated that co-cultivation is a remarkably successful approach for the discovery of new bioactive natural products ([@B24]; [@B26]; [@B9]; [@B10]), and an overview is provided by [@B20]. Moreover, microbial co-cultivation has been shown to increase the titre of a specific metabolite in some cases, for example for the yew tree fungal endophyte *Paraconiothyrium*, responsible for production of the potent anticancer drug paclitaxel. The concentration of this alkaloid was raised to approximately eightfold when the producer strain was co-cultivated with other fungal community members such as the bark-derived fungi *Alternaria* sp. or *Phomopsis* sp. ([@B33]). Recently, our group has demonstrated the efficiency of the co-culture approach when investigating hyper-arid desert bacterial isolates ([@B26]). In the course of that previous study, when screening a series of fungal isolates, we identified strains of *Aspergillus fumigatus* to be particularly responsive to the presence of other microbes. These results prompted us to investigate further isolates of the same fungal species from other habitats. In the present study, we report on the co-cultivation of the marine-derived fungal isolate *A. fumigatus* MR2012, and our findings indicate for the first time the dual induction of newly detected bacterial and fungal metabolites that were not traced previously.

Materials and Methods {#s1}
=====================

General Experimental Procedures
-------------------------------

Optical rotations were recorded using a Perkin-Elmer 343 polarimeter. UV and IR spectra were measured on a Perkin-Elmer Lambda 25 UV-vis spectrometer and a Thermo Nicolet IR 100 FT-IR spectrometer, respectively. NMR data were acquired on a Varian VNMRS 600 MHz NMR spectrometer. High resolution mass spectrometric data were obtained using a Thermo LTQ Orbitrap coupled to an HPLC system (PDA detector, PDA autosampler, and pump). The following conditions were used: capillary voltage of 45 V, capillary temperature of 260°C, auxiliary gas flow rate of 10-20 arbitrary units, sheath gas flow rate of 40-50 arbitrary units, spray voltage of 4.5 kV, and mass range of 100-2000 amu (maximal resolution of 30000). For LC/MS, a C18 analytical HPLC column (5 μm, 4.6 mm × 150 mm) was used with a mobile phase of 0 to 100% MeOH over 30 min at a flow rate of 1 mL min^-1^. A Biotage Flash system (Part No: SP1-XOB1) Charlottesville, WA, United States was used for initial fractionation. Preparative HPLC separations were conducted using a C18 column (5 μm, 100 Å, 10 mm × 250 mm), connected to a binary pump, and monitored using a photodiode array detector.

Microbial Strains
-----------------

The marine fungal isolate MR2012 used in this study was isolated from a Red Sea sediment in Hurghada, Egypt in September 2011, and taxonomically identified on a molecular basis as *A. fumigatus* ([@B11]). The two bacterial isolates C34 and C58 were collected from the hyper-arid soil of Laguna de Chaxa, Salar de Atacama, Chile and identified as *Streptomyces leeuwenhoekii* subspecies C34 and C58, respectively ([@B23]).

Fermentation, Extraction, and Isolation
---------------------------------------

Three different media; ISP2 ([@B32]), GYE medium composed of (g/L) glucose 10, yeast extract 10, and F-medium ([@B35]) composed of (g/L) sucrose 100, glucose 10, casamino acids 0.1, yeast extract 5, MOPS (3-*N*-morpholinopropanesulfonic acid) 21, K~2~SO~4~ 0.25 × 10^-6^, MgCl~2~ 6H~2~O 1.0 × 10^-6^, were used for small scale fermentation to screen for secondary metabolite production. The seed culture of each strain was prepared by inoculating 50 mL of liquid ISP2 medium with a single colony of the bacteria or a small piece (approximately 1 cm^2^) of agar containing fungal mycelia, respectively, and incubating for 3 days at 30°C with shaking at 180 rpm. Then, 2.5 mL of the primary culture was used to inoculate 250 mL of each of the three media. To adjust fermentation parameters and ensure reproducibility of secondary metabolite production before commencing large scale cultivation, screening of secondary metabolite profiles was conducted using LC-HRESIMS and LC-UV (in duplicate). The growth of both bacterial and fungal mycelia in their axenic or co-cultures, respectively, was also checked microscopically at different time intervals during the fermentation process (data not shown).

For large scale production, the seed culture of each strain was prepared as described above. Then 200 mL primary seed culture of each of fungal and bacterial isolates were used to inoculate 4 L of ISP2 medium as production medium in duplicate. For co-culture experiments, inoculation of the primary fungal culture was started 2 days before bacterial inoculation. Then, incubation of the secondary culture was conducted for 8 days at 30°C with shaking at 180 rpm as before. At the end of the incubation period, 50 g/L Diaion HP-20 resin was added to the culture media and shaken for 6 h at 180 rpm, then cultures were centrifuged (3000 rpm for 20 min) where the residue composed of cell mass and resin were washed with distilled water twice and extracted with MeOH, and subjected to LC-HRESIMS analysis. This extract was fractionated successively with *n*-hexane (3 mL × 250 mL), CH~2~Cl~2~ (3 mL × 300 mL), and then EtOAc (3 mL × 250 mL). Each solvent fraction was evaporated *in vacuo* and subjected to LC-HRESIMS and ^1^H NMR analysis, which revealed that the CH~2~Cl~2~ fraction was the one of interest for the fungal isolate and both fungal bacterial co-culture experiments. This CH~2~Cl~2~ fraction for each of the three fermentations was loaded on Flash Biotage using a FLASH 65i cartridge, solvent methanol/water 0--100%, flow rate 60 mL/min over 20 min and UV collection wavelengths 225 and 254 nm to produce six fractions. All of these fractions were monitored by LC-HRESIMS.

For the pure fungal isolate MR2012, fraction 3 was subjected to Sephadex LH-20 column using CH~2~Cl~2~:MeOH 1:1 as a mobile phase to obtain three subfractions A--C. Further purification of fraction B on Agilent HPLC system using semi-preparative Sunfire C18 column (250 mm × 10 mm, 5 μm) with CH~3~CN:H~2~O 40--80% over 30 min with a 2 mL/min flow led to the isolation of 0.9 mg of **1**.

For the fungal isolate MR2012/bacterial isolate C34 co-culture experiment, fraction 3 was directly subjected to HPLC using the same column with CH~3~CN:H~2~O 25--60% over 30 min and 2 mL/min flow which led to the isolation of 1.2 mg of **2**. Additionally, the injection of fraction 5 on HPLC using the same column with CH~3~CN:H~2~O 40--90% over 30 min and 2 mL/min flow led to the isolation of 0.8 mg of **3**.

Brevianamide X **1**: white amorphous; \[α\]^25^~D~ -86.9 (*c* 0.18, MeOH); UV (MeOH) λ~max~, nm (log 𝜀) 225 (4.62), 278 (3.90), 285 (2.85), 295 (3.70); IR (KBr) ν~max~ (cm^-1^) 3275, 1698, 1275, 1126; ^1^H and ^13^C NMR data were described in **Table [1](#T1){ref-type="table"}**; HRESIMS: *m/z* 350.1470 \[M+Na\]^+^ (calcd for C~18~H~21~O~3~N~3~, 350.1475).

###### 

Summary of ^1^H (600 MHz) and ^13^C (150 MHz) NMR spectroscopic data for brevianamide X **1** and luteoride D **2** in DMSO at 298 K.

  -------------------------------------------------------------------------------
        Brevianamide X 1   Luteoride D 2                       
  ----- ------------------ -------------------- -------------- ------------------
  1                                                            6.60 (d, 1.6)

  2     127.9, CH          7.28 (s)             80.4, CH       5.03 (d, 1.7)

  3     110.0, C                                74.8, C        

  4     128.2, C                                132.3, C       

  5     118.8, CH          7.61 (d, 8.1)        122.0, CH      7.02 (d, 7.8)

  6     119.0, CH          7.06 (t, 7.9)        117.9, CH      6.63 (t, 7.6)

  7     121.3, CH          7.15 (t, 8.1)        125.2, CH      7.31 (d, 7.8)

  8     109.8, CH          7.50 (d, 8.2)        118.8, C       

  9     135.9, C                                147.0, C       

  10    25.3, CH~2~        3.24 (m), 3.08 (m)                  

  11    54.9, CH           4.33 (t, 4.9)        143.2, C       

  12                       7.86 (s)             29.9, CH~2~    3.16 (d, 15.7),\
                                                               2.79 (d, 15.7)

  13    168.7, C                                155.0, C       

  14    58.1, CH           4.07 (t, 8.6)        124.6, CH      6.69 (d, 16.0)

  15                                            129.9, CH      6.80 (d, 16.1)

  16    165.2, C                                142.4, C       

  17    44.4, CH~2~        3.40 (m), 3.27 (m)   116.4, CH~2~   5.11 (br s),\
                                                               5.01 (br s)

  18    21.5, CH~2~        1.70 (m), 1.65 (m)   18.5, CH~3~    1.94 (s)

  19    27.5, CH~2~        2.00 (q), 1.41 (m)                  

  20    76.1, CH~2~        5.46 (s)                            

  OMe   55.0, CH~3~        3.14 (s)             52.6, CH~3~    3.61 (s)
  -------------------------------------------------------------------------------

1

Extracted from HSQC and HMBC.

Luteoride D **2**: white amorphous; \[α\]^25^~D~ -36.3 (*c* 0.12, MeOH); UV (MeOH) λ~max~, nm (log 𝜀) 212 (4.12), 258 (3.83), 329 (3.64); IR (KBr) ν~max~ (cm^-1^) 3315, 2950, 1720, 1432, 1340, 1215, 1135; ^1^H and ^13^C NMR data were described in **Table [1](#T1){ref-type="table"}**; HRESIMS: *m/z* 315.1338 \[M+H\]^+^ (calcd for C~17~H~18~N~2~O~4~, 315.1339).

Pseurotin G **3**: light yellow amorphous; \[α\]^25^~D~ -11.3 (*c* 0.14, MeOH); UV (MeOH) λ~max~, nm (log 𝜀) 213 (3.62), 259 (4.12), 285 (3.74); IR (KBr) ν~max~ (cm^-1^) 3242, 1712, 1681, 1605, 1124; ^1^H and ^13^C NMR data were described in **Table [1](#T1){ref-type="table"}**; HRESIMS: *m/z* 550.2177 \[M+H\]^+^ (calcd for C~29~H~31~O~8~N~3~, 550.2184).

Results
=======

In our previous work on fungal-bacterial co-culture, it became evident that the addition of the bacterial isolate was the trigger to initiate the production of fungal secondary metabolites ([@B26]). In the current study, we aimed to monitor the effects of both bacteria and fungi on the induction of microbial secondary metabolites when inoculated in the same culture vessel. Before conducting microbial co-culture experiments, the chemical profiles of each strain were separately investigated using the OSMAC approach to obtain a maximum number of compounds produced, using a variety of media and both low and high nutrient conditions. Once the metabolite profile for each of these three strains was confirmed, the co-cultivation experiment was conducted.

The axenic marine-derived fungal isolate *A. fumigatus* MR2012 ([@B11]) was screened using three different media followed by media and mycelia extraction. Fractionation and multiple steps of SiO~2~ and Sephadex LH-20 followed by reversed phase semi-preparative HPLC purification led to the isolation and identification of a new metabolite belonging to the diketopiperazine family named brevianamide X **1** (**Figure [1](#F1){ref-type="fig"}**), in addition to the known metabolites brevianamide F **4**, cyclo([L]{.smallcaps}-pro-[L]{.smallcaps}-val), cyclo([L]{.smallcaps}-pro-[L]{.smallcaps}-ile), cyclo([L]{.smallcaps}-pro-[L]{.smallcaps}-phe), cyclo([L]{.smallcaps}-pro-[L]{.smallcaps}-leu), fumitremorgin C, spirotryprostatin A, 6-methoxy-spirotryprostatin C ([@B11]), pseurotin A ([@B26]), *bis*(dethio)*bis*(methylthio)gliotoxin ([@B2]), and azaspirofurans A and B ([@B29]). These metabolites were identified based on comparing their spectral data with published data.

![Compounds isolated from the microbial co-culture of *Aspergillus fumigatus* MR2012 and *Streptomyces leeuwenhoekii* strains C34 and C58 in addition to that isolated from the axenic marine-derived *A. fumigatus* MR2012.](fmicb-08-01284-g001){#F1}

The molecular formula of **1** was established as C~18~H~21~O~3~N~3~ based on the HRESIMS analysis which gave an \[M+Na\]^+^ quasimolecular ion at *m/z* 350.1470. The analysis of ^1^H, ^13^C and multiplicity-edited HSQC NMR spectral data (**Table [1](#T1){ref-type="table"}**) revealed the presence of two amide groups (δ~C~ 168.7, 165.2), a methoxy group (δ~C~ 55.0/δ~H~ 3.14), a methylene group attached to oxygen and nitrogen (δ~C~ 76.1/δ~H~ 5.46), a 1,2-disubstituted benzene ring (δ~H~ 7.61, 7.06, 7.15, 7.50), an olefinic singlet at δ~H~ 7.3, two α-protons at (δ~C~ 54.9/δ~H~ 4.33) and (δ~C~ 58.1/δ~H~ 4.07), four methylene groups, and an NH group at δ~H~ 7.86 (s).

The COSY correlations of H-14 through H~2~-17 confirmed the proline ring substructure (**Figure [2](#F2){ref-type="fig"}**) and that of H-5 through to H-8 established the 1,2-disubstituted benzene ring, along with an olefinic singlet at δ~H~ 7.28 which indicated an indole moiety. This was confirmed by the HMBC correlations of H-2 to both C-4 and C-9, H-5 to C-3 and H-8 to C-4. The HMBC correlations of H~2~-10 to C-2, C-3, C-11 and C-19, H-14 to C-13 and H-11 to both C-13 and C-16 established the presence of an indolyl proline diketopiperazine skeleton which was identical to brevianamide F **4** structure (**Figure [2](#F2){ref-type="fig"}**) according to spectroscopic data comparison. The HMBC correlations of H~2~-20 to C-9, C-2 and C-21 were the key in the determination of the new substructure and its connection to the rest of the brevianamide F **4** structure (**Figure [2](#F2){ref-type="fig"}**). Since both **4** and **1** shared the same NOESY correlations, virtually identical ^13^C NMR spectral data and optical rotation values, and are assumed to be formed via a similar non-ribosomal peptide biosynthetic route, we proposed **1** to have the same absolute configuration as brevianamide F ([@B39]). Hence, **1** was identified as a new marine fungal metabolite for which we propose the name brevianamide X.

![Key COSY correlations in bold and HMBC correlations shown with arrows of compounds **1**--**3**.](fmicb-08-01284-g002){#F2}

Our previous investigation of the Atacama Desert bacterial isolates *S. leeuwenhoekii* strains C34 and C58 led to the isolation of the ansamycin derivatives, chaxamycins ([@B27]), the macrolactin derivatives, chaxalactins in addition to the sedirophore nocardamine from *S. leeuwenhoekii* C34 ([@B28]), and the lasso peptide chaxapeptin from *S. leeuwenhoekii* C58 ([@B12]). All of these previously described compounds were identified in the current study using LC-HRESIMS analysis (**Figures [3](#F3){ref-type="fig"}**, **[4](#F4){ref-type="fig"}**). As observed during our previous study, the profile pattern of *S. leeuwenhoekii* strain C34 changed markedly in the OSMAC approach ([@B28]), while it was fairly constant for *S. leeuwenhoekii* strain C58.

![LC comparison of the microbial co-culture of *A. fumigatus* MR2012 and *S. leeuwenhoekii* strain C34 on ISP2 medium.](fmicb-08-01284-g003){#F3}

![LC comparison of the microbial co-culture of *A. fumigatus* MR2012 and *S. leeuwenhoekii* strain C58 on ISP2 medium.](fmicb-08-01284-g004){#F4}

However, we observed a dramatic change in chemical profiles when each of the two bacteria was separately co-cultured together with the fungus as described in the experimental section. At this stage we carried out large scale co-cultivation, extraction and chromatographic separation, which was guided by focusing on unique peaks with retention times and UV spectra observed in the HPLC profiles which were not present in the profiles of either strain when cultivated on its own. **Table [2](#T2){ref-type="table"}** represents all bacterial and fungal metabolites identified in axenic and co-culture flasks of these micro-organisms.

###### 

Summary of the metabolites detected by LCMS in bacterial and fungal axenic culture and co-culture experiments.

  Media                                            Strain C34   Strain C58   Fungus MR2012   Fungus/C34   Fungus/C58                            
  ------------------------------------------------ ------------ ------------ --------------- ------------ ------------ ---- ---- ---- ---- ---- ----
  Brevianamide F                                   \-           \-           \-              \-           \-           \-   \+   \-   \+   \-   \-
  Brevianamide X                                   \-           \-           \-              \-           \-           \-   \-   \-   \+   \-   \-
  Cyclo([L]{.smallcaps}-pro-[L]{.smallcaps}-val)   \-           \-           \-              \-           \-           \-   \+   \+   \-   \-   \+
  Cyclo([L]{.smallcaps}-pro-[L]{.smallcaps}-ile)   \-           \-           \-              \-           \-           \-   \+   \+   \-   \-   \+
  Cyclo([L]{.smallcaps}-pro-[L]{.smallcaps}-phe)   \-           \-           \-              \-           \-           \-   \+   \+   \-   \-   \+
  Cyclo([L]{.smallcaps}-pro-[L]{.smallcaps}-leu)   \-           \-           \-              \-           \-           \-   \+   \+   \+   \-   \+
  Fumitremorgin C                                  \-           \-           \-              \-           \-           \-   \+   \-   \-   \-   \-
  Spirotryprostatin C                              \-           \-           \-              \-           \-           \-   \+   \-   \-   \-   \-
  Pseurotin A                                      \-           \-           \-              \-           \-           \-   \+   \+   \+   \-   \-
  B*is*(dethio)*bis*(methylthio)gliotoxin          \-           \-           \-              \-           \-           \-   \+   \-   \+   \-   \-
  Azaspirofuran A                                  \-           \-           \-              \-           \-           \-   \+   \-   \+   \-   \-
  Azaspirofuran B                                  \-           \-           \-              \-           \-           \-   \+   \-   \+   \-   \-
  Chaxamycins A--D                                 \+           \-           \+              \-           \-           \-   \-   \-   \-   \-   \-
  Chaxalactins A--C                                \+           \-           \-              \-           \-           \-   \-   \-   \-   \-   \-
  Nocardamine                                      \+           \+           \+              \-           \-           \-   \-   \-   \-   ++   ++
  Chaxapeptin                                      \-           \-           \-              \+           \+           \+   \-   \-   \-   \+   ++
  Terezine D                                       \-           \-           \-              \-           \-           \-   \-   \-   \-   \+   \-
  Luteride D                                       \-           \-           \-              \-           \-           \-   \-   \-   \-   \+   \-
  Methylpseurotin A                                \-           \-           \-              \-           \-           \-   \-   \-   \-   \+   \-
  Pseurotin G                                      \-           \-           \-              \-           \-           \-   \-   \-   \-   \+   \-
  Pentalenic acid                                  \-           \-           \-              \-           \-           \-   \-   \-   \-   \-   \+

The microbial co-culture of *A. fumigatus* MR2012 and *S. leeuwenhoekii* strain C34 on ISP2 medium (**Figure [3](#F3){ref-type="fig"}**) led to the production of the bacterial metabolite chaxapeptin **7**, the gene cluster of which is known to be present in the bacterial strain. However, no chaxapeptin production was obtained when the bacterium was fermented using six different media and different cultivation parameters during previous studies ([@B28]; [@B13]). On the other hand, all other bacterial metabolites that were previously detected were not produced in the current co-culture experiment, except for nocardamine. Interestingly, the HPLC profile of the co-culture was dominated by fungal metabolites, including the known diketopiperazine terezine D **5**, the new luteoride derivative luteoride D **2**, the known 11-*O*-methylpseurotin A **6**, and a new pseurotin derivative, pseurotin G **3**. None of these compounds were observed when the fungus was cultivated on its own.

HRESIMS analysis afforded an \[M+H\]^+^ quasimolecular ion at *m/z* 315.1338, establishing the molecular formula of **2** as C~17~H~18~N~2~O~4~. The analysis of ^1^H, ^13^C and multiplicity-edited HSQC NMR spectral data (**Table [1](#T1){ref-type="table"}**) indicated the presence of a methoxy group (δ~C~ 52.6/δ~H~ 3.61), a methyl group connected to a double bond (δ~C~ 18.5/δ~H~ 1.94), a methylene group (δ~C~ 29.9/δ~H~ 3.16, 2.79), a geminal olefinic methylene group (δ~C~ 116.4/δ~H~ 5.11, 5.01), a 1,2,3-trisubstituted benzene ring (δ~H~ 7.02, 6.63, 7.31), a hemiaminal (δ~C~ 80.4/δ~H~ 5.03), and a disubstituted *E*-olefinic moiety \[δ~H~ 6.69 (d, 16.0) and 6.80 (d, 16.1)\].

The COSY correlations of H-5 through H-7, 1-NH to H-2, and the HMBC correlations of 1-NH to C-8 and C-3, H-2 to C-9, C-3 and C-12, H-5 to C-3 and C-9 confirmed the presence of indoline ring substructure substituted at position 8 (**Figure [2](#F2){ref-type="fig"}**). The COSY correlations of H-14 to H-15, H~2~-17 to H~3~-18 and the HMBC correlations of H~3~-18 to C-15, C-16 and C-17, H-15 to C-8 and H-14 to C-7 indicated a 2-methylpenta-1,3-dienyl moiety connected to the indoline ring at position 8. The HMBC correlations of the methyl group at δ~H~ 3.61 to C-13 indicated a -COOCH~3~ group. The remaining two double bond equivalents as well as one nitrogen and one oxygen implied by the molecular formula, were attributed by the presence of an oxazine ring connected to the indoline moiety. This was confirmed by the HMBC correlations of H~2~-12 to C-2, C-3 and C-11, establishing a dihydro-\[1,2\]oxazino\[6,5-*b*\]indol-4a(4H)-ol moiety, and the connection of the -COOCH~3~ group was corroborated through the HMBC correlations of H~2~-12 to C-13. No NOEs for either H-2 or 3-OH were observed in DMSO-*d*~6~ or CD~3~OD, so the relative configuration at these two positions could not be determined. Thus, compound **2** was identified as a new natural product for which the name luteoride D is proposed. Although indoline moieties are frequently encountered in fungal natural products, to the best of our knowledge this is the first report of a oxazino\[6,5-*b*\]indole nucleus in nature. Based on inspection of its structure, **2** may be formed from the known luteoride A via nucleophilic attack of oxime OH moiety to the olefinic carbon of the indole ring. The latter compound is a prenylated tryptophan analog that was reported recently from the entomopathogenic fungus *Torrubiella luteorostrata* when induced by the histone deacetylase inhibitor suberoyl *bis*-hydroxamic acid ([@B3]).

The molecular formula C~29~H~31~O~8~N~3~ was established for compound **3** based on the HRESIMS a \[M+H\]^+^ quasimolecular ion at *m/z* 550.2177. The analysis of the ^1^H, ^13^C, and multiplicity-edited HSQC NMR data of **3** (**Table [3](#T3){ref-type="table"}**) indicated the presence of a monosubstituted benzene ring (δ~H~ 8.27, 7.83, 7.54), a 1,2-disubstituted benzene ring (δ~H~ 7.96, 7.24, 6.65, 6.52), a disubstituted *Z* double bond (*J* = 10.9 Hz), one aliphatic and one allylic methyl group at δ~C/H~ 13.7/0.81 and 5.42/1.67, respectively, one O-methyl group at δ~C/H~ 51.4/3.23, four carbonyls including one α,β-unsaturated ketone at δ~C~ 196.5, one ketone at δ~C~ 196.1, and two amide groups at δ~C~ 171.2 and 171.9, two NH groups (δ~H~ 8.43 and 9.96), and a oxygenated tetrasubstituted olefinic bond (δ~C~ 185.8 and 111.5). Comparison with reported data ([@B37]) indicated that **3** belonged to the pseurotin family of compounds.

###### 

Summary of ^1^H (600 MHz) and ^13^C (150 MHz) NMR spectroscopic data for pseurotin G **3** in DMSO at 298 K.

          Pseurotin G 3   
  ------- --------------- --------------------
  2       185.8, C        
  3       111.5, CH       
  4       196.5, C        
  5       90.9, C         
  6       171.9, C        
  8       92.4, C         
  9       74.7, CH        4.50 (s)
  10      70.6, CH        4.63 (s)
  11      52.2, CH        4.50 (s)
  12      134.6, CH       5.48 (m)
  13      125.3, CH       5.30 (m)
  14      20.5, CH~2~     2.03 (m), 1.94 (m)
  15      13.7, CH~3~     0.81 (t, 7.4)
  16      5.42, CH~3~     1.67 (s)
  17      196.1, C        
  18      133.3, C        
  19/23   130.7, CH       8.27 (d, 7.9)
  20/22   128.2, CH       7.54 (t, 7.8)
  21      133.7, CH       7.68 (t, 7.3)
  24      51.4, CH~3~     3.23 (s)
  26      148.0, C        
  27      111.4, C        6.65 (d, 8.9)
  28      132.1, CH       7.24 (t, 7.6)
  29      114.5, CH       6.52 (t, 7.6)
  30      129.0, CH       7.56 (d, 7.6)
  31      114.2, C        
  32      171.2, C        
  7-NH                    9.96 (s)
  25-NH                   8.43 (d, 8.2)

1

Extracted from HSQC and HMBC.

The COSY correlations (**Figure [2](#F2){ref-type="fig"}**) confirmed the location of the two OH groups, confirmed the identity of the two aromatic rings, and established the chain from H-10 through H~3~-15. The HMBC correlation from H-19/23 to C-17 confirmed the attachment of the mono-substituted benzene ring to the carbonyl C-17, while the di-substituted benzene ring was identified as part of an anthranilamide moiety on the basis of HMBC correlations of H-30 to C-32 and of NH-25 to both C-27 and C-31. The attachment of the latter to the pseurotin core at position 11 was confirmed through the COSY correlation of NH-25 to H-11 and HMBC correlation of NH-25 to C-12. Furthermore, the mono-substituted benzene ring was connected to the pyrrolidinone moiety through the carbonyl C-17 as evident from HMBC correlations of both NH-7 and H-9 to C-17. The HMBC correlation of H-9 to C-4 confirmed the spirocyclic system, while the furanone ring was established on the basis of correlation between H~3~-16 to C-2, C-3, and C-4. Since both pseurotin A and **3** share the same NOESY correlations, displayed virtually identical ^13^C spectral data and optical rotation values, we assume **3** to have the same absolute configuration as pseurotin A, and propose the name pseurotin G for this new metabolite. A putative biosynthetic route leading to **3** is shown in Supplementary Figure [S14](#SM1){ref-type="supplementary-material"} based on the biosynthetic pathway of pseurotin A published by [@B36].

The microbial co-culture of *A. fumigatus* MR2012 and *S. leeuwenhoekii* strain C58 on ISP2 medium (**Figure [4](#F4){ref-type="fig"}**) led to the production of four simple diketopiperazines assumed to be produced by the fungus, since they were also observed in the axenic culture of the fungus. However, the titre of bacterial metabolite chaxapeptin **7** was dramatically increased, and additionally, the bacterium was induced to produce the known bacterial sesquiterpene pentalenic acid **9**, which had previously been isolated from various *Streptomyces* spp. ([@B34]), and the known siderophore, nocardamine **8**. The latter two were not observed in single cultures of the bacterium under different fermentation conditions. Based on inspection of their structures, these three compounds clearly are bacterial metabolites, and additionally, the gene clusters responsible for their biosynthesis were confirmed to be present in the genome of *S. leeuwenhoekii* strain C58 (data not shown). All three bacterial compounds were identified based on their HRESIMS analysis and comparison with the previously reported NMR data ([@B27]; [@B12]).

Discussion
==========

In the past few years, various researchers have established microbial co-cultivation as a powerful tool for mimicking the natural microbial environment and enhancing the production of specific metabolites, or inducing the production of new secondary metabolites not previously observed in the independent strain cultures. Activation of cryptic biosynthetic genes in a second microorganism may be stimulated through microbial crosstalk and may be interpreted as a defense mechanism triggered in response to a chemical signal from the other microorganism ([@B25]; [@B31]). Ten years ago, the application of co-cultivation (mixed fermentation) was still in its infancy, probably due to the fear of lack of reproducibility ([@B25]) but since then, various studies have demonstrated that this approach is capable of delivering reproducible metabolite patterns, provided relevant fermentation parameters are first established and then carefully maintained.

In the present study, small scale fermentation of axenic cultures of bacteria and fungi, and of their co-cultures was conducted at different conditions, and was carefully monitored by LC-HRESIMS, LC-UV and microscopic analysis (data not shown) to adjust fermentation parameters and ensure reproducibility of secondary metabolite production. Once an optimized set of fermentation parameters was established, a large scale co-culture experiment was conducted at a scale of 4 L for natural product isolation. Chemical profiles observed for small and large scale cultivation were highly comparable (data not shown). Our selection of *A. fumigatus* as the fungal component was established as a results of a broader screening of different fungal strains, which revealed this species to be particularly prone to respond by displaying modified metabolite profiles upon co-cultivation with other microorganisms (data not shown). During the preliminary chemical screening of various isolates of *A. fumigatus*, strain MR2012 which had been obtained from a Red Sea sediment sample caught our attention as it produced a new metabolite, brevianamide X **1**, which was only observed upon fermentation in F-medium, but not in two other culture media. This finding highlights the importance of varying culture conditions and of using a variety of fermentation media for screening ([@B17]).

To date, co-culture studies reported the effect of one microorganism to affect the metabolite profile of the second microorganism. Our current investigation not only showed that co-culture can induce the production of new metabolites, but highlighted the fact that this may work in both directions. Comparing the chemical profiles of the pure cultures to those from the co-culture, a great diversity was shown (**Figures [3](#F3){ref-type="fig"}**, **[4](#F4){ref-type="fig"}**). In the microbial co-culture of *A. fumigatus* MR2012 and *S. leeuwenhoekii* C34, the bacterial strain appears to have suppressed the production of most of fungal metabolites detected in the axenic culture. However, it induced the production of two fungal prenylated indole metabolites which were not traced before in the fungus; the known terezine D and the new luteoride D **2** featuring an oxazino\[6,5-*b*\]indole nucleus that was not previously reported in nature. Additionally, the new compound, pseurotin G **3** was also induced in the fungus. Based on analysis of its structure, **3** is assumed to be of hybrid polyketide and non-ribosomal peptide origin as was demonstrated for pseurotin A ([@B36]). A putative biosynthetic route for **3** is provided in Supplementary Figure [S14](#SM1){ref-type="supplementary-material"}. It is interesting to note that fungi have been found to readily incorporate anthranilamide or anthranilic acid ([@B38]; [@B18]). Thus, the origin of the respective substructure in **3** which so far has not been observed for other pseurotin derivatives, i.e., whether it is produced by the fungus itself or by the bacterium, or may be even incorporated from the culture medium, cannot be established at this point.

Surprisingly, in the co-cultivation experiments of *A. fumigatus* MR2012 and *S. leeuwenhoekii* C34, the fungus appears to have suppressed all ansamycin and macrolactin derivatives that previously were observed in axenic cultures of the bacterium ([@B28]), while the lasso peptide chaxapeptin was produced at significant levels. Whereas genome scanning had revealed the presence of the chaxapeptin biosynthetic gene cluster in *S. leeuwenhoekii* C34 ([@B13]), our previous chemical analysis had failed to detect the expression of this metabolite when the bacterium was fermented using six different media and a variety of cultivation parameters ([@B28]). It is worth noting that the production of antimicrobial lasso peptides could be triggered by competing nutrient scarcity in the culture vessel ([@B15]).

In the microbial co-culture of *A. fumigatus* MR2012 and *S. leeuwenhoekii* C58, the bacterial strain appears to have suppressed the production of the fungal metabolites that were present in the axenic culture. However, the bacterium was induced to produce pentalenic acid and nocardamine, both of which were not observed in the single bacterial culture under different fermentation conditions. Additionally, the titre of the lasso peptide chaxapeptin was greatly increased. It is worth noting that none of these metabolites proved to have antifungal effects when screened in previous studies.

Interestingly, siderophores such as nocardamine have been identified as auto-regulator/quorum sensing molecules ([@B5]). In order to assess whether the effects observed in the present study are due to some metabolites acting as signaling molecules, or may be explained in terms of mere antimicrobial effects, further studies need to be conducted.

In summary, co-cultivation is an ecologically driven approach which has become a powerful method to induce previously unexpressed biosynthetic pathways and increase the metabolic capacity of chemically prolific microorganisms beyond the boundaries that can be reached by routine axenic cultivation. In this current study, a bi-lateral cross talk that led to dual induction of both bacterial and fungal metabolites in the same culture flask was proved for the first time.
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